Project Grant HT94252510194

This $1,072,500 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Trustees of Tufts College (Tufts University School of Medicine) to investigate methods of reducing post-traumatic epilepsy. The research project aims to block the MIAT signaling pathway in parvalbumin-positive inhibitory GABAergic interneurons, which may help prevent the development of epilepsy following traumatic brain injuries. Tufts University School of Medicine, a leading academic medical institution, will conduct this biomedical research over a 3-year period from April 2025 to March 2028. The findings could contribute to improved treatments and outcomes for military personnel and others affected by post-traumatic epilepsy.